PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $503.62 | -0.7% | -6.2% | -6.7% | -13.5% | +35.6% | +190.4% | +493.5% | |
| TTM Revenue | $1.28B | +13.4% | – | +13.4% | – | +149.0% | +100.0% | +100.0% | |
| TTM EPS | -$12.88 | -0.7% | – | -0.7% | – | -0.3% | +30.9% | +11.8% | |
| 22.22 | -0.7% | -6.0% | -3.0% | +0.7% | +87.3% | -28.2% | +327.3% | ||
| 9.06 | -0.8% | -6.0% | -17.6% | -34.7% | -43.4% | – | – | ||
| $11.14B | -0.8% | -6.2% | -7.0% | -12.0% | +47.1% | +271.1% | +926.4% | ||
| -34.71 | +0.8% | +6.2% | +9.6% | +18.1% | -41.3% | -281.4% | -643.3% | ||
| Market Cap | $12B | -0.7% | -6.0% | -6.5% | -12.5% | +41.0% | +263.4% | +726.0% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 3.62 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 0.92 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 2.17 | - |
Formula
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl
